

The Long Run with Luke Timmerman
Timmerman Report
"The Long Run"
Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.
Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.
Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Episodes
Mentioned books

Jun 14, 2021 • 1h 33min
Ep93: Jay Bradner & Andy Plump on Mentoring Young Scientists
Ep93: Jay Bradner of Novartis & Andy Plump of Takeda on Mentoring Young Scientists

Jun 1, 2021 • 1h 12min
Ep92: Brad Gray on Spatial Biology
NanoString Technologies CEO Brad Gray on tools for spatial biology.

May 3, 2021 • 52min
Ep91: Daphne Zohar on Biotech Entrepreneurship
Daphne Zohar, CEO of Puretech Health, on starting biotech companies.

Apr 19, 2021 • 1h 1min
Ep90: James Sabry on Partnering Amid Scientific Abundance
James Sabry, global head of pharma partnering for Roche, on partnering in a time of scientific abundance.

Mar 29, 2021 • 1h 5min
Ep89: Emily Leproust on DNA Synthesis at Scale
Emily Leproust, co-founder and CEO of Twist Bioscience, on DNA Synthesis at Scale

Mar 15, 2021 • 1h 5min
Ep88: Amy DuRoss on software and logistics for cell and gene therapy
Amy DuRoss, CEO of Vineti, on software and logistics for cell and gene therapy.

Mar 1, 2021 • 49min
Ep87: Bob Nelsen of ARCH Venture Partners on Biotech Investing
Bob Nelsen of ARCH Venture Partners on long-term trends in biotech investing.

Feb 9, 2021 • 1h 9min
Ep86: Sek Kathiresan on a Gene-Edited Single Shot for Heart Disease
Sekar Kathiresan, co-founder and CEO of Verve Therapeutics, on a gene edited single shot for cardiovascular disease.

Jan 20, 2021 • 47min
Ep85: Luhan Yang on CRISPR Editing for Organ Transplants
Luhan Yang, CEO of Qihan Bio, on CRISPR editing for organ transplants.

Dec 22, 2020 • 1h 9min
Ep84: Steve Paul on Treatments for Mental Health
Steve Paul, CEO of Karuna Therapeutics, on neuropsychiatric drug development.